- Home
- NVR vs DXCM Comparison
NVR vs DXCM Comparison
Compare NVR & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVR
- DXCM
- Stock Information
- Founded
- NVR 1980
- DXCM 1999
- Country
- NVR United States
- DXCM United States
- Employees
- NVR N/A
- DXCM N/A
- Industry
- NVR Homebuilding
- DXCM Medical/Dental Instruments
- Sector
- NVR Consumer Discretionary
- DXCM Health Care
- Exchange
- NVR Nasdaq
- DXCM Nasdaq
- Market Cap
- NVR 28.2B
- DXCM 28.0B
- IPO Year
- NVR N/A
- DXCM 2005
- Fundamental
- Price
- NVR $8,952.58
- DXCM $78.92
- Analyst Decision
- NVR Buy
- DXCM Buy
- Analyst Count
- NVR 3
- DXCM 17
- Target Price
- NVR $10,025.00
- DXCM $101.29
- AVG Volume (30 Days)
- NVR 21.1K
- DXCM 3.9M
- Earning Date
- NVR 01-28-2025
- DXCM 10-24-2024
- Dividend Yield
- NVR N/A
- DXCM N/A
- EPS Growth
- NVR 2.79
- DXCM 83.21
- EPS
- NVR 488.66
- DXCM 1.67
- Revenue
- NVR $10,281,399,000.00
- DXCM $3,954,000,000.00
- Revenue This Year
- NVR $6.32
- DXCM $13.10
- Revenue Next Year
- NVR $5.91
- DXCM $14.79
- P/E Ratio
- NVR $18.33
- DXCM $47.33
- Revenue Growth
- NVR 3.41
- DXCM 16.19
- 52 Week Low
- NVR $6,330.74
- DXCM $62.34
- 52 Week High
- NVR $9,964.77
- DXCM $142.00
- Technical
- Relative Strength Index (RSI)
- NVR 40.68
- DXCM 61.33
- Support Level
- NVR $9,100.00
- DXCM $77.50
- Resistance Level
- NVR $9,256.14
- DXCM $82.26
- Average True Range (ATR)
- NVR 181.82
- DXCM 2.48
- MACD
- NVR 5.60
- DXCM 0.42
- Stochastic Oscillator
- NVR 33.97
- DXCM 65.74
About NVR NVR Inc.
NVR Inc is a United States-based homebuilding company. It builds single-family detached homes, townhomes, and condominium buildings under three brands, Ryan Homes, NVHomes, and Heartland Homes. The company through its subsidiary also operates a mortgage banking and title services business. The homebuilding segment includes four geographic areas of the United States; Mid-Atlantic, North East, Mid-East, and South East.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.